Bioscan
Washington
About Bioscan
Bioscan, Inc. develops instrumentation for the detection, synthesis, and imaging of radio labeled compounds used in life science research, molecular imaging, pharmaceutical development, and nuclear medicine fields. It offers single photon emission computed tomography and positron emission tomography imaging systems for preclinical applications. The company’s molecular imaging products include in vivo preclinical imagers and small-animal environment systems. Its PET/nuclear medicine products comprise chemistry synthesizers, radiochemistry laboratory products, and FDG production lab products. The company’s life sciences products include analytical and quality-control instruments for chemical purity and quality-control testing of radiopharmaceuticals. Bioscan, Inc. was founded in 1980 and is based in Washington, District of Columbia with an additional office in Paris, France.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $3.3M
- Funding stage: M&A
- Last round: Debt Financing (Jun 2011)
- Website: bioscan.com
- Phone: 202-338-0974
Industries & Categories
Biotechnology, Developer Platform, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/bioscan-3234021 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.